Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Mutations00:36

Viral Mutations

39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging Multistep s‑Triazine Oligomerization via Cobalt-Assisted Deamination and Selective C-C Coupling.

Precision chemistry·2026
Same author

Clinicopathological and molecular features of wild-type gastrointestinal stromal tumors identified by targeted NGS.

Histology and histopathology·2026
Same author

Methodological Evaluation of a P2C-Based ReMOT CRISPR/Cas9 System in <i>Aedes aegypti</i>.

Insects·2026
Same author

Profiling peripheral MDSCs and Tregs in breast cancer: clinical significance and prediction of lymph node metastasis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Prevalence, trends, and determinants of early-onset type 2 diabetes in northwest China: a sex-stratified analysis of ∼10 million community-dwelling population.

Diabetes research and clinical practice·2026
Same author

Dosimetric impact of two multileaf collimator systems in simultaneous integrated boost volumetric modulated arc therapy for lymph node metastases in stage IIIC cervical cancer.

Frontiers in oncology·2026
Same journal

Research hotspots and trend analyses of maximum biosafety level pathogens: A bibliometric study using China's 2023 catalogue of pathogens as an example.

Biosafety and health·2026
Same journal

Building internationally competitive journals for science data sharing: The evolution of three biomedical English academic journals launched in China.

Biosafety and health·2026
Same journal

Genomic phylogenetic characterization of <i>Brucella abortus</i> biovar 1 from a human case in Yunnan Province, China.

Biosafety and health·2026
Same journal

Establishment and application of a rapid and visual detection method for <i>Mycoplasma pneumoniae</i> using enzymatic recombinase amplification combined with lateral flow dipstick.

Biosafety and health·2026
Same journal

A semi-quantitative risk assessment of pathogenic microorganism laboratories in Beijing's CDCs based on a three-dimensional risk matrix model.

Biosafety and health·2026
Same journal

Cellular miR-24-3p inhibits vaccinia virus replication by targeting kinesin-like protein KIF21B.

Biosafety and health·2026
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.8K

Chikungunya virus: Current situation and future challenges.

Teng Zhao1, Teng Chen1, Jie Zhang1,2

  • 1State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.

Biosafety and Health
|January 16, 2026
PubMed
Summary
This summary is machine-generated.

Chikungunya virus (CHIKV) is a growing global threat, spreading to over 100 countries. This review covers CHIKV virology, epidemiology, evolution, vaccines, and vector control strategies for effective management.

Keywords:
Aedes aegyptiAedes albopictusChikungunya virus (CHIKV)EpidemiologyVaccine

More Related Videos

Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus
10:35

Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus

Published on: May 31, 2020

3.4K
Experimental Viral Infection in Adult Mosquitoes by Oral Feeding and Microinjection
08:02

Experimental Viral Infection in Adult Mosquitoes by Oral Feeding and Microinjection

Published on: July 28, 2022

2.9K

Related Experiment Videos

Last Updated: Jan 18, 2026

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
06:18

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1

Published on: March 13, 2018

14.8K
Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus
10:35

Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus

Published on: May 31, 2020

3.4K
Experimental Viral Infection in Adult Mosquitoes by Oral Feeding and Microinjection
08:02

Experimental Viral Infection in Adult Mosquitoes by Oral Feeding and Microinjection

Published on: July 28, 2022

2.9K

Area of Science:

  • * Arbovirology and Virology
  • * Public Health and Epidemiology
  • * Vector-borne Diseases

Background:

  • * Chikungunya virus (CHIKV), an alphavirus, emerged in 1952 and now affects over 100 countries.
  • * Recent outbreaks in Réunion Island and China highlight its increasing global dissemination risk.
  • * Primary vectors, Aedes aegypti and Aedes albopictus, exhibit behaviors that enhance CHIKV transmission and complicate control efforts.

Purpose of the Study:

  • * To review current knowledge on CHIKV.
  • * To summarize CHIKV virology, epidemiology, and evolution.
  • * To provide insights into CHIKV vaccines and vector control for managing this re-emerging arboviral threat.

Main Methods:

  • * Comprehensive literature review of CHIKV.
  • * Analysis of epidemiological data and disease spread.
  • * Evaluation of vaccine development and vector control strategies.

Main Results:

  • * CHIKV has demonstrated significant global expansion, posing substantial public health risks.
  • * Specific vector behaviors of Aedes mosquitoes increase CHIKV transmission potential.
  • * Multiple vaccine candidates (live-attenuated, virus-like particle, inactivated, mRNA) are in development, with some licensed.

Conclusions:

  • * Effective management of CHIKV requires a multi-faceted approach.
  • * Continued research into CHIKV, its vectors, and novel control strategies is crucial.
  • * Vaccination and integrated vector management are key to mitigating the impact of this re-emerging arbovirus.